LXEO
Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. (LXEO) has 13 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 1, 2026.
The most active filer is Chief Operating Officer Otero Jose Manuel with 4 filings. Insiders have net sold $684K over the trailing 6 months.
- Industry:Biotechnology
- CEO:R. Nolan Townsend
- Employees:75
- HQ:New York City, US
- IPO:2023-11-03
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$684K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$357.3M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Tamayo Louis EdwardFirst filing | Chief Financial Officer | Sale | 4,641 | $21K | Jul 1 | SEC ↗ |
| Chief Operating Officer | Sale | 4,666 | $21K | Jul 1 | SEC ↗ | |
Bhalla Narinder PalFirst filing | Chief Medical Officer | Sale | 22,306 | $99K | Jul 1 | SEC ↗ |
| Chief Executive Officer | Sale | 25,947 | $116K | Jul 1 | SEC ↗ | |
| Chief Executive Officer | Sale | 3,342 | $17K | May 20 | SEC ↗ | |
| Chief Operating Officer | Sale | 1,302 | $7K | May 20 | SEC ↗ | |
| Chief Executive Officer | Sale | 55,000 | $313K | Apr 7 | SEC ↗ | |
Otero Jose ManuelFirst filing | Chief Operating Officer | Sale | 721 | $7K | Feb 20 | SEC ↗ |
Otero Jose ManuelFirst filing | Chief Operating Officer | Sale | 3,016 | $19K | Feb 20 | SEC ↗ |
Townsend Richard NolanFirst filing | Chief Executive Officer | Sale | 10,173 | $65K | Feb 20 | SEC ↗ |
Related companies
Lexeo Therapeutics, Inc. is in the Healthcare sector.